Y-mAbs Therapeutics
YMAB
YMAB
100 hedge funds and large institutions have $303M invested in Y-mAbs Therapeutics in 2022 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 29 increasing their positions, 32 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
100
Holders Change
+9
Holders Change %
+9.89%
% of All Funds
1.73%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
16
Increased
29
Reduced
32
Closed
7
Calls
$1.78M
Puts
–
Net Calls
+$1.78M
Net Calls Change
-$802K
Top Buyers
Top Sellers
1 |
1
AllianceBernstein
Nashville,
Tennessee
|
$31M |
2 |
![]()
2
Fidelity Investments
Boston,
Massachusetts
|
$19.9M |
3 |
3
Morgan Stanley
New York
|
$3.68M |
4 |
4
Invesco
Atlanta,
Georgia
|
$242K |
5 |
5
Dimensional Fund Advisors
Austin,
Texas
|
$1.91M |